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Abstract 
Docosahexaenoic acid (DHA) is the longest and most unsaturated of the n - 3 fatty acids found in membranes. Although a number of 
membrane properties have been demonstrated to be affected by the presence of this fatty acid, its mode of action has yet to be clearly 
elucidated. Prior reports on biological membranes have not distinguished the effect of mono-docosahexaenoyl phospholipids from those 
caused by phospholipids containing docosahexaenoic acid in both chains. This report compares properties of monolayers and bilayers 
composed of either 1-stearoyl-2-1inolenoyl-sn-glycero-3-phosphocholine (as a control), 1-stearoyl-2-docosahexaenoyl-sn-glycero-3- 
phosphocholine or 1,2-di-docosahexaenoyl-sn-glycero-3-phosphocholine. When compared to the mono-DHA phosphatidylcholine (PC), 
the di-DHA PC occupies a much larger area/molecule, supports a more fluid and permeable bilayer, and is less susceptible to 
peroxidation. Monolayers made from either phospholipid are not condensable by cholesterol. We suggest many of the membrane 
properties linked to the presence of DHA may be the result of phospholipids which have lost their normal positional selectivity and have 
incorporated DHA into both positions. 
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1. Introduction 
Docosahexaenoic a id (DHA, 22:6A 4'7'10'13'16'19) is the 
longest and most unsaturated of the class of polyunsatu- 
rated fatty acids known as n -  3. These fatty acids have 
recently received considerable attention because they have 
been linked with reduced heart disease, autoimmune dis- 
eases, multiple sclerosis, arthritis, peroxisomal disorders 
and cancer [1-6]. While the precise mode of action of 
n - 3 fatty acids remains a mystery, their participation in 
seemingly unrelated disease states implies a fundamental 
Abbreviations: AS, (9-anthroyloxy)stearic a id; CF, carboxyfluo- 
rescein; DHA, docosahexaenoic acid; DPH, 1,6-diphenyl- 1,3,5-hexatriene; 
MLV, multilamellar vesicles; PC, phosphatidylcholine; PE, phosphatidyl- 
ethanolamine; PROP-DPH, 3-p-(6-phenyl)-l,3,5-hexatrienylphenylpro- 
pionic acid; SUV, small unilamellar vesicles; 18:0,18:1 PC, 1-stearoyl-2- 
oleoyl-sn-glycero-3-phosphocholine; 18:0,18:3 PC, l-stearoyl-2-1inolen- 
oyl-sn-glycero-3-phosphocholine; 18:0,22:6 PC, 1-stearoyl-2-docosahexa- 
enoyl-sn-glycero-3-phosphocholine; 22:6,22:6 PC, 1,2-di-docosahexaen- 
oyl-sn-glycero-3-phosphocholine. 
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role which would be common among many cell types. 
Three categories of activities have been suggested: n - 3 
fatty acids may be involved in the biochemical production 
of prostinoids; they may serve as the source of very potent 
peroxidation products; or they may serve unique structural 
roles as components of the hydrophobic interior of mem- 
branes. The experiments reported here explore the role of 
n - 3 in membrane structure. 
DHA is typically found in large amounts only in the rod 
outer segment, sperm and the gray matter of brain [7]. In 
these tissues DHA levels can occasionally exceed 50 mol% 
of the fatty acids found associated with a class of phospho- 
lipids. For example, Neil and Masters [8] found 78.8% of 
the phosphatidylcholine acyl chains in bovine spermatozoa 
were DHA, while Wiegand and Anderson [9] reported 62% 
of the acyl chains of frog outer segment phosphatidyl- 
ethanolamine (PE) were DHA. The most common arrange- 
ment of acyl chains in phospholipids finds saturated chain 
fatty acids such as palmitic and stearic acid predominantly 
in the sn-I position and unsaturated fatty acids such as 
oleic, linoleic or DHA in the sn-2 position [10]. The high 
levels of DHA reported for certain tissues implies the 
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existence of significant amounts of phospholipids in which 
DHA must occupy both acyl chain positions. Dipolyenoic 
phospholipids have in fact been reported from several 
types of membranes, most notably from rod outer seg- 
ments [11,12]. The frog ROS PE composition reported by 
Wiegand and Anderson [9] had 25% of the PEs containing 
two DHA chains. While it is assumed that n -3  fatty 
acids should provide a unique function, it has yet to be 
elucidated what that function might be. 
There have been a few reports of alterations in mem- 
brane properties caused by mixed acyl chain 18:0,22:6 PC 
[13-16]. With the exception of the recent differential 
scanning calorimetry study of Kariel et al. [17], however, 
there are no reports of bilayer properties affected by 
incorporation of phospholipids where both chains are DHA. 
Here we compare several properties of monolayers and 
bilayers made from phosphatidylcholines in which DHA 
occupies only the sn-2 position or where DHA occupies 
both positions. 
stirred in the dark, under nitrogen for a period of 16 h. 
After acylation, the suspension was filtered, washed with 
chloroform and concentrated by rotary evaporation and 
then subjected to chromatography on a Rexyn 1300 col- 
umn [19], eluted with 2 beds column of 
CH30H/CHCI3/H20 (5:4:1). The column eluant was 
converted into the phase system of Folch et al. [20] and the 
lower phase collected. The resulting mixture, after concen- 
tration, was separated by CM-cellulose column chromatog- 
raphy using step-wise elution with solvents containing 
increasing percentages of methanol in chloroform [21]. 
Purity of the synthesized phospholipid was tested by silica 
gel TLC using CHCI3/CH3OH/H,O (65:25:4, v /v)  and 
the total phospholipid content was determined by spec- 
trophotometry assay for phosphorus according to Chen et 
al. [22]. The yield of 22:6,22:6 PC was between 40-45% 
of the starting lycerophosphorylcholine. 
2.3. Preparation of small unilamellar t:esicles (SUVs) 
2. Materials and methods 
2.1. Materials 
The phosphatidylcholines 18:0,18:1 PC, 18:0,18:3 PC 
and 18:0,22:6 PC were purchased from Avanti Polar Lipids, 
Alabaster, AL. CM cellulose, hydroxybenzotriazole, 4-(di- 
methylamino)pyridine, L-a-glycerophosphorylcholine, 
N,N'-dicyclohexylcarbodiimide and Sephadex G-50 were 
from Sigma (St. Louis, MO). tert-Butylhydroquinone was 
purchased from Aldrich (Milwaukee, WI), Rexyn 1300 
from Fisher, carboxyfluorescein from Eastman Kodak 
(Rochester, NY) and the fluorescent membrane probes 
DPH, PROP-DPH, 2-AS, 6-AS, 9-AS, and 12-AS from 
Molecular Probes (Eugene, OR). 
2.2. Synthesis of 1,2-di-docosahexaenoyl-sn-glycero-3- 
phosphocholine (22:6,22:6 PC) 
A modification of the procedure of Rhodes et al. [18] 
was used to synthesize 22:6,22:6 PC. To minimize auto- 
oxidation, all procedures were performed in reduced light 
and under nitrogen. Water was scrupulously removed from 
all reagents and glassware. The reaction was carried out in 
two steps: synthesis of DHA-anhydride was subsequently 
followed by the esterification of L-c~-glycerophosphor- 
ylcholine. DHA (100 nag, 0.305 mmol), tert-butylhydro- 
quinone (12.45 mg, 0.075 mmol), p-hydroxybenzotriazole 
(10.12 mg, 0.075 mmol), N, N'-dicyclohexylcarbodiimide 
(79.30 rag, 0.380 retool) were dissolved in 5 ml of 
dimethylformamide ( oubly distilled) and the solution was 
stirred for 45 min at room temperature under an atmo- 
sphere of nitrogen. Then L-o~-glycerophosphorylcholine 
(19.30 mg, 0.76 mmol) and 4-(dimethylamino)pyridine 
(18.33 mg, 0.152 mmol) were added. The mixture was 
Phospholipids in chloroform were dried under nitrogen, 
then vacuum pumped overnight. Multilamellar vesicles 
(MLVs) were made by hydration in 10 mM Na2HPO ~ 
buffer, pH 7.0. The turbid suspension was then sonicated 
on ice for 5 rain at level 3 using a Heat System W-380 
Cell Disrupter. The resultant clear suspension, comprised 
of small unilamellar vesicles (SUVs), was then centrifuged 
at low speed to remove titanium and non-liposomal parti- 
cles and was immediately used for experimentation. 
2.4. Lipid peroxidation 
Lipid peroxidation of SUVs by CH2804/H202 in 50 
mM Tris, pH 7.0, was determined by measuring conju- 
gated diene formation spectrophotometrically with tandem 
cuvettes [23,24]. The same amount of oxidizable poly- 
unsaturated fatty acid was tested for each phospholipid. 
Since 22:6,22:6 PC has two oxidizable chains and the 
other two phospholipids, 18:0,18:3 PC and 18:0,22:6 PC, 
have only one, 22:6,22:6 PC was run at half the concentra- 
tion of the other phospholipids. For this lipid the total lipid 
concentration was maintained by mixing 22:6,22:6 PC 
with non-oxidizable 18:0,18:1 PC (l : l ,  tool/tool) [24]. 
Prior to peroxidation, SUVs were diluted (1:5) in Tris 
buffer, then 1.5 ml of the diluted mixture was added to the 
first compartment of the tandem cuvettes in both the 
reference and the sample beam. The second compartment 
of both tandem cuvettes was filled with 1.5 ml of the 
buffer. Lipid peroxidation was initiated by addition of 20 
/~1 of H20 2 and 20 /,tl of Cu2SO 4 to the sample cuvette 
lipid compartment and to the reference cuvette buffer 
compartment, 40 /xl of Milli-Q water was added to both 
the lipid-containing compartment of the reference cuvette 
and to the buffer-containing compartment of the sample 
cuvette. The final concentration f lipid in the cuvettes was 
70 /zM, and Cu2SO 4 and H202 were 130 /.tM and 1.3 
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mM, respectively. Temperature of the cuvettes was 37 ° C. 
UV difference spectra (205-300 nm) were recorded con- 
tinuously on an Aminco SLM 3000 diode array spectro- 
photometer, 
2.5. Fluorescence anisotropy 
Two types of fluorescent probe are used to monitor the 
effect of DHA on the property of membrane fluidity. 
Relative membrane fluidity was followed by steady-state 
fluorescence polarization of either the membrane interior 
(linear) probe 1,6-diphenyl-l,3,5-hexatriene (DPH) [25], 
the membrane surface (linear) probe 3-p-(6-phenyl)-l,3,5- 
hexatrienylphenylpropionic acid (PROP-DPH) [26] or a 
series of (9-anthroyloxy)stearic acids (non-linear probes) 
with the chromophore attached at the 2-, 6-, 9- or 12-posi- 
tion of stearic acid [27]. While the term membrane fluidity 
has proven to be very difficult to precisely define [28], the 
probes employed here report on some combination of 
degree of order and rate of motion. For the linear (DPH) 
probes, motion predominates while for the non-linear (AS) 
probes the dependency on degree of order becomes in- 
creasingly more significant. Although a precise definition 
of fluidity is not attainable, it is believed these probes in 
combination can be used qualitatively to report on the state 
of the bilayer at various positions down the acyl chains. 
SUVs were made as described above from 18:0,18:3 
PC, 18:0,22:6 PC or 22:6,22:6 PC mixed with the appro- 
priate probe. Lipid concentration was between 1-1.5 mM 
with a probe to lipid ratio of 1:200. Anisotropy values (A) 
were measured at 25°C using a Perkin-Elmer MPF-66 
Fluorescence Spectrophotometer interfaced to a Perkin- 
Elmer 7700 professional computer. The excitation and 
emission wavelengths were: DPH, 360 nm and 420 nm; 
PROP-DPH, 358 nm and 426 nm; and the AS probes, 361 
and 446 nm, respectively. A values are the average of 
eight determinations for each sample. 
lipids in 60 mM CF, 30 mM KC1, 10 mM Na2HPO 4, pH 
7.0 then SUVs were made as described above. Non- 
sequestered CF was removed on a Sephadex G-50 column 
with 90 mM KC1 and 10 mM Na2HPO 4, pH 7.0. The 
resultant vesicles were kept on ice until used. CF perme- 
ability was initiated by rapidly mixing a small aliquot of 
SUVs with 2.5 ml of 90 mM KC1/10 mM Na2HPO 4 pH 7 
at 25 ° C. Fluorescence was followed on a Perkin-Elmer LS 
50B Luminescence spectrometer at 25 ° C. Excitation was 
at 490 nm and emission at 520 nm. Total sequestered CF 
was obtained following SUV breakage by addition of 50 
/zl of 5% Triton X-100. Percent CF leakage was deter- 
mined by: 
%CF = (( F - Fi)/Fmax) × 100 
where F= fluorescence intensity at time t; Fma x is the 
maximum fluorescence following Triton X-100 release; 
and F i is the initial fluorescence at time t -- 0. 
2.7. Lipid monolayer studies 
Measurements of area/molecule were made on lipid 
monolayers using a KSV minitrough (KSV Instrument, 
Helsinki, Finland) interfaced to Epson 286 PC. Lipids, 
dissolved in triply distilled benzene at 1 mg/ml ,  were 
spread onto a subphase of 20 mM Na2HPO 4, pH 7.0. 
After 10 min to allow evaporation of solvent, film com- 
pression (1 mN/m/min)  at 22°C was initiated. Each 
compression was repeated a minimum of four times. 
Area/molecule determinations were made for single com- 
ponent 18:0,18:3 PC, 18:0,22:6 PC, 22:6,22:6 PC or 
cholesterol monolayers or for 80:20, 70:30, 60:40 or 50:50 
mixtures of phospholipid/cholesterol (mol/mol).  The ex- 
tent of cholesterol condensation was estimated from the 
value of the sum of the ideal (noncondensable) areas for 
the lipid plus cholesterol and the experimentally derived 
value for the mixture [30,31]. The reported % condensation 
then reflects the deviation from ideal behavior. 
2.6. Carboxyfluorescein permeability 2.8. Statistical analysis 
Permeability of SUVs from 18:0,18:3 PC, 18:0,22:6 PC 
and 22:6,22:6 PC was followed by monitoring the increase 
in fluorescence intensity resulting from carboxyfluorescein 
(CF) leakage [29]. MLVs were made by hydrating the 
For comparison of values, Student's t-test was em- 
ployed in the cholesterol condensation and fluidity experi- 
ments. Statistical significance between all other groups 
was determined by analysis of variance (ANOVA) and the 
Table 1 
The calculated area/molecule (~2) for 18:0,18:3 PC, 18:0,22:6 PC, and 22:6,22:6 PC monolayers at lateral surface pressures of 10, 20, 30, and 40 mN/m 
Phospholipid Area/molecule (,~2) 
10 mN/m 20 mN/m 30 mN/m 40 mN/m 
18:0,18:3 PC 80.75 4- 1.97 a 65.83 -t- 1.74 a 54.50 4- 1.86 a 45.26 4- 0.70 a 
18:0,22:6 PC 101.00 ± 3.10 b 80.67 -I- 1.42 b 68.33 _+ 2.78 b 54.50 4- 0.42 b 
22:6,22:6 PC 125.75 ___ 4.85 c 95.00 + 1.42 c 82.20 + 1.18 ~ 75.00 4- 1.26 c 
The subphase was 20 mM Na2HPO4, pH 7.0. Values are means 4- S.E. from four separate determinations. Values with different superscripts (a,b, c) are 
significantly different (P < 0.05, ANOVA). 
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Fig. 1. Surface pressure-area curves for monolayers composed of: (A) 
18:0,18:3 PC; (B) 18:0,22:6 PC and (C) 22:6,22:6 PC. Phospholipids 
were spread in benzene over a sub-phase of 20 mM Na2HPO4, pH 7.0 at 
22 ° C. Compression rates were 1 mM/m/min.  
Scheffe F-test. Differences were considered significant if 
P < 0.05. 
3. Results 
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Fig. 3. Cholesterol-induced condensation of 18:0,18:3 PC monolayers as 
a function of membrane cholesterol content. Cholesterol/18:0,18:3 PC 
(mol/mol) were 20:80, 30:70, 40:60, 50:50. Lateral pressures are: (A) 15 
mN/m; (B) 20 raN/m; and (C) 25 mN/m. Phospholipids were spread in 
benzene over a sub-phase of 20 mM Na2HPO4, pH 7.0 at 22°C. 
Compression rates were 1 mM/m/min.  (Average + S.E., n = 6 individ- 
ual determinations. * P < 0.01, * ~ P < 0.001 compared to the sum of 
the area/molecule of individual lipid.) 
Lipid monolayers and phospholipid bilayer vesicles 
(SUVs) were made from 18:0,18:3 PC, 18:0,22:6 PC or 
22:6,22:6 PC. Area/molecule and cholesterol-induced 
condensation determinations were made using the lipid 
monolayers while lipid peroxidation, fluidity, and bilayer 
permeability were monitored with lipid vesicles. 
Monolayers were made from 18:0,18:3 PC, 18:0,22:6 
PC or 22:6,22:6 PC over an aqueous ubphase of 20 mM 
Na~HPO 4, pH 7.0. Compressions were made at 1 
mN/m/min  on a KSV minitrough (Fig. 1) and the area 
per molecule calculated for each lipid at 10, 20, 30 and 40 
mN/m (Table 1). At all pressures di-22:6 PC occupied 
about 1.3-times the area as did 18:0,22:6 PC and about 
1.75-times the area as did 18:0,18:3 PC. Upon addition of 
30, 40 and 50 mol% cholesterol, monolayers made from 
18:0,18:3 PC were shown to exhibit statistically significant 
condensation at 15, 20 and 25 mN/m lateral pressure (Fig. 
3). An increase in % condensation was measured with 
increasing % cholesterol at all lateral pressures tested. In 
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Fig. 2. Surface pressure-area curves for monolayers composed of: (A) 
cholesterol; (B) 22:6,22:6 PC and (C) cholesterol/22:6,22:6 PC 1:1 
(mol/mol). Phospholipids were spread in benzene over a sub-phase of 20 
mM Na2HPO 4, pH 7.0 at 22 ° C. Compression rates were 1 mM/m/min.  
contrast, at these same pressures, neither the 18:0,22:6 PC 
nor the 22:6,22:6 PC could be condensed by cholesterol 
(Figs. 2 and 4). 
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Fig. 4. Cholesterol-induced condensation f: 18:0,18:3 PC (D); 18:0,22:6 
PC (0) ;  and 22:6,22:6 PC ( t )  at lateral pressures of 10, 15 and 25 
mN/m. Lipids (cholesterol/phospholipid, 1:1) were spread in benzene 
over a sub-phase of 20 mM Na2HPO4, pH 7.0 at 22°C. Compression 
rates were 1 mM/m/min.  (Average of four separate determinations; all 
S.E. < 0.5%. Significantly different than the sum of the area of lipid + 
cholesterol, * P < 0.01, * * P < 0.001, one tailed Student's t-test.) 
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Table 2 
Rates of lipid peroxidation and carboxyfluorescein (CF) leakage from SUVs made fi'om 18:0,18:3 PC, 18:0,22:6 PC and 22:6,22:6 PC 
Phospholipids 
18:0,18:3 PC 18:0,22:6 PC 22:6,22:6 PC 
Peroxidation AABS (233 nm/min × 10 4) 15 _+3 ~ 60 +4 h 30 _+6 c 
CF leakage (%/min) 0.3 _+ 0.01 ~ 0.6 _+ 0.03 b 1.2 _+ 0.04 c 
Rates of peroxidation by CuSO4/H202 (37 ° C) are reported as absorbance changes (232 nm) due to conjugated iene formation. Carboxyfluorescein 
leakage is reported as an increase in fluorescence ( xcitation at 490 nm, emission at 520 nm). (Average +_ S.E., n = 4 individual determinations, values 
with different superscripts a, b, c are significantly different from each other, P < 0.05 ANOVA.) 
Polyunsaturated fatty acids are known to be particularly 
susceptible to peroxidation. Table 2 compares the rates of 
Cu2SO4/HzO 2 induced peroxidation for phospholipid 
vesicles made from either polyunsaturated 18:0,18:3 PC, 
18:0,22:6 PC or 22:6,22:6 PC. As discussed above, 
18:0,18:1 PC vesicles were added as a non-peroxidizable 
lipid [24] to the 22:6,22:6 PC vesicles in order to maintain 
the same amount of lipid in each experiment. With lipid 
vesicles containing equivalent amounts of polyunsaturated 
acyl chains, the rate of 18:0,22:6 PC peroxidation is about 
2-times greater than 22:6,22:6 PC and about 4-times greater 
than 18:0,18:3 PC. 
Membrane fluidities of phospholipid vesicles composed 
of 18:0,18:3 PC, 18:0,22:6 PC or 22:6,22:6 PC were 
followed using the fluorescent probes 2-AS, 6-AS, 9-AS 
0.15- 
0.1- 
U~ 
0.05- 
2AS 6AS 9AS 12AS PROP-  DPH 
DPH 
LABEL 
Fig. 5. Relative membrane fluidities of SUVs made from 18:0,22:6 PC 
(11) or 22:6,22:6 PC (0 )  as monitored by fluorescence anisotropy (A) of 
the membrane probes 2-AS, 6-AS, 9-AS, 12-AS, DPH or PROP-DPH 
(25 ° C). The excitation and emission wavelength were: DPH, 360 nm and 
420 nm; PROP-DPH, 358 nm and 426 nm; and the AS probes, 341 and 
446 nm, respectively. (Average of six separate determinations; all S.E. < 
0.5%. * Significantly different than SUVs made from 18:0,22:6 PC, 
P < 0.001, Student's t-test.) 
and 12-AS as well as the membrane interior probe DPH 
and the membrane surface probe PROP-DPH (Fig. 5). The 
shape of the fluidity gradient profiles, measured with the 
AS probes, looked similar for both 18:0,22:6 PC and 
22:6,22:6 PC. The di-22:6 PC, however, had lower anisot- 
ropy values (higher elative fluidity) than did the 18:0,22:6 
PC at all four membrane depth positions tested. The DPH 
and PROP-DPH probes supported these observations, as 
22:6,22:6 PC had lower A values than did 18:0,22:6 PC at 
the membrane surface (PROP-DPH) and the membrane 
interior (DPH). In agreement with our previous report [32], 
fluidity of 18:0,18:3 PC bilayers was similar to that of 
membranes composed of 18:0,22:6 PC (results not shown). 
Finally, we compared the permeability rates for phos- 
pholipid vesicles composed of 18:0,18:3 PC, 18:0,22:6 PC 
or 22:6,22:6 PC (Table 2). 22:6,22:6 PC was 2-times more 
permeable to carboxyfluorescein than was 18:0,22:6 PC 
and was 4-times more permeable than 18:0,18:3 PC. 
4. Discussion 
To date most studies involving DHA and membranes 
have reported DHA-related changes in a membrane func- 
tion without identifying the chemical species in which 
DHA was found. Even in those experiments in which 
DHA was shown to be associated with a specific phospho- 
lipid, there usually has been no distinction made between 
the mono and di-DHA species. DHA levels are consis- 
tently high in three tissues, the rod outer segment, sperm 
and gray matter of the brain [7], where some of the 
phospholipids most certainly contain DHA in both acyl 
chains [17]. DHA levels in other membranes can vary over 
a wide range depending on the diet. In membranes altered 
by dietary DHA, it is possible that di-DHA phospholipids 
also exist in significant amounts and account for the 
reported DHA-induced alterations in membrane function. 
Whatever effect DHA-incorporation i to phospholipids has 
on membrane structure-function, it may be amplified when 
the fatty acid is found in both chains. The only report on 
the effect of 22:6,22:6 PC on a membrane property is that 
of Kariel et al. [17] who measured phase behavior by 
differential scanning calorimetry. The work presented here 
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extends the differential scanning calorimetry report of 
Kariel et al. [17] on the phase behavior of bilayers com- 
posed of 22:6,22:6 PC to a variety of membrane proper- 
ties. 
Previously we reported that DHA did not affect mem- 
brane fluidity to a degree significantly different han did 
other polyunsaturated fatty acids [32]. 18:0,18:3 PC vesi- 
cles and 18:0,22:6 PC vesicles had almost identical fluidi- 
ties as monitored by the membrane probes DPH and 2-, 6-, 
9-, and 12-anthracene stearic acids [32]. In contrast he 
18:0,22:6 PC vesicles were far more fusogenic and perme- 
able than were vesicles made from 18:0,18:3 PC [32]. We 
[13] and others [30,31] have also reported that 18:0,22:6 
PC monolayers are not condensable by cholesterol while 
many other PC monolayers are. In fact most phosphatidyl- 
cholines commonly found in biological membranes are 
cholesterol condensable. Using differential scanning 
calorimetry, Kariel et al. [17] have recently reported that 
cholesterol at up to 50 mol% has little or no effect on the 
position, width or AH of the 22:6,22:6 PC transition in 
bilayers. They conclude that cholesterol does not affect he 
packing of di-22:6 PC in bilayers and that perhaps it is 
excluded from domains that might be rich in this phospho- 
lipid. Our lipid monolayer data presented here concur with 
the conclusions of Kariel et al. [17] and support our 
previous proposal that DHA may function in membranes 
by inducing lateral phase separation into DHA-rich, 
cholesterol-poor and DHA-poor, cholesterol-rich domains 
[13]. If such lipid domains do indeed exist, their unique 
compositions would induce individual protein segregation 
resulting in local variations in biochemical activity. The 
existence of cholesterol domains has been suggested from 
several studies [33,34]. 
Here we report that incorporation of DHA into both 
chains makes phosphatidylcholine bilayers more fluid than 
those in which DHA is incorporated into just one chain 
(Fig. 5). The increased bilayer fluidity is felt from the 
aqueous interface (as monitored by PROP-DPH) through 
to the bilayer interior (as followed by 12-AS and DPH). 
These fluidity measurements are consistent with reported 
phase transition temperatures obtained from differential 
scanning calorimetry (18:0,22:6 PC, -7°C  and 22:6,22:6 
PC, -68.4° C [17]). The increase in bilayer fluidity paral- 
lels an increase in permeability as we have shown that 
di-DHA PC bilayers are 2-times as permeable to carboxy- 
fluorescein as are bilayers made from mono-DHA PC 
(Table 2). We anticipate the large enhancement in mem- 
brane permeability we previously reported for lipid bilay- 
ers [16,32], tumor cell plasma membranes [15,16,35] and 
mouse and rat liver mitochondria (Stillwell et al., unpub- 
lished results) caused by 18:0,22:6 PC supplementation 
would be even further enhanced by incorporation of 
22:6,22:6 PC. Experiments confirming this hypothesis are 
currently in progress. 
From lipid monolayer studies (Fig. 1 and Table 1) we 
report that replacing the sn-I stearic acid chain with a 
second DHA chain increases the area/molecule for phos- 
phatidylcholine containing DHA in the sn-2 position by 
about 1.3-fold. Like 18:0,22:6 PC monolayers, di-DHA PC 
monolayers are also not condensable with cholesterol. If
our prediction that mono-DHA phospholipid can induce 
lateral phase separation into DHA-rich, cholesterol-poor 
domains is correct [13], then we would expect that the 
di-DHA lipid would also induce lateral phase separation. 
A major problem with proposing a biologically signifi- 
cant membrane structural role for DHA-containing phos- 
pholipids is the extreme susceptibility of DHA to peroxida- 
tion. In Table 2 we report that incorporation of a second 
DHA into phosphatidylcholine significantly decreases 
DHA's oxidation potential. 
We predict hat if significant levels of di-DHA PC do 
exist in biological membranes, they might be found in 
cholesterol-poor domains which would be very fluid, very 
permeable and would be partially resistant to peroxidation. 
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